Darbepoetin AlfaIts Use in Anemia Associated with Chronic Kidney Disease

被引：0
|
作者：
Dean M. Robinson
Stephanie E. Easthope
机构：
[1] Adis International Inc.,
来源：
BioDrugs | 2005年 / 19卷
关键词：
Chronic Kidney Disease; Peritoneal Dialysis; Chronic Kidney Disease Patient; Darbepoetin Alfa; rhEPO Therapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：327 / 343
页数：16
相关论文
共 50 条
  • [41] Anemia treatment patterns in chronic kidney disease in pre-dialysis patients using darbepoetin alfa (NESP)
    Lunde, Martin
    Fahrbach, Kyle
    Nalysnyk, Luba
    del Aguila, Michael
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2007, 49 (04) : A57 - A57
  • [42] Use of darbepoetin alfa (Aranesp) in pediatric kidney disease
    McTaggart, S.
    Alexander, S.
    Craig, J.
    Henning, P.
    Hodson, E.
    Jones, C.
    Jureidini, F.
    Lewis, D.
    Powell, H.
    Burke, J.
    PEDIATRIC NEPHROLOGY, 2007, 22 (09) : 1472 - 1472
  • [43] Anemia management preferences in chronic kidney disease (CKD) patients converted to oncemonthly (QM) ARANESP® (darbepoetin alfa)
    Vainer, A
    Hoggard, J
    Koenig, K
    Prathikanti, R
    Scarlata, D
    Globe, D
    Audhya, P
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2005, 45 (04) : A54 - A54
  • [44] Efficacy and safety of vadadustat compared to darbepoetin alfa on anemia in patients with chronic kidney disease: a meta-analysis
    Huang, Qiong
    Liao, Zhenyi
    Liu, Xiaoyan
    Xia, Yun
    Wang, Jing
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2023, 55 (02) : 325 - 334
  • [45] Hepcidin as a therapeutic target for anemia and inflammation associated with chronic kidney disease
    Malyszko, Jolanta
    Malyszko, Jacek S.
    Matuszkiewicz-Rowinska, Joanna
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2019, 23 (05) : 407 - 421
  • [46] Therapeutic innovations in the management of chronic kidney disease-associated anemia
    Aniort, Julien
    Greze, Clarisse
    Kosmadakis, George
    NEPHROLOGIE & THERAPEUTIQUE, 2022, 18 (06): : 6S25 - 6S32
  • [47] Anemia and the associated risk of hospitalization in chronic kidney disease (CKD) patients
    Kliger, A
    Burrows-Hudson, S
    Robbins, S
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2003, 41 (04) : A24 - A24
  • [48] Erythropoietic effects of vadadustat in patients with anemia associated with chronic kidney disease
    Koury, Mark J.
    Agarwal, Rajiv
    Chertow, Glenn M.
    Eckardt, Kai-Uwe
    Fishbane, Steven
    Ganz, Tomas
    Haase, Volker H.
    Hanudel, Mark R.
    Parfrey, Patrick S.
    Pergola, Pablo E.
    Roy-Chaudhury, Prabir
    Tumlin, James A.
    Anders, Robert
    Farag, Youssef M. K.
    Luo, Wenli
    Minga, Todd
    Solinsky, Christine
    Vargo, Dennis L.
    Winkelmayer, Wolfgang C.
    AMERICAN JOURNAL OF HEMATOLOGY, 2022, 97 (09) : 1178 - 1188
  • [49] Pharmacokinetics of darbepoetin alfa in pediatric patients with chronic kidney disease
    Gary Lerner
    Arundhati S. Kale
    Bradley A. Warady
    Kathy Jabs
    Timothy E. Bunchman
    Anne Heatherington
    Kurt Olson
    Louise Messer-Mann
    Bradley J. Maroni
    Pediatric Nephrology, 2002, 17 : 933 - 937
  • [50] Considerations for optimal iron use for anemia due to chronic kidney disease
    Hudson, JQ
    Comstock, TJ
    CLINICAL THERAPEUTICS, 2001, 23 (10) : 1637 - 1671
12345